Studies Don't Lie

Studies Don't Lie

The Solution’s Effects are Science-Based

The Solution’s Effects are Science-Based

Despite the many claims you may have seen across the internet as brands promise the fountain of youth, not all collagen can claim the same benefits and skin effects. In fact, there are large variations in the results one can expect from using different types of collagen on the market – where one collagen might be close to the fountain of youth, another may just be an expensive protein supplement.  

Although all collagen formulas vary in ingredients and production techniques, most collagen companies use the same studies to back up their claims of age-prevention and improved skin appearance. These studies include the ones that have been published on the effects of oral intake of Verisol® trademark collagen peptides, which are used in The Solution™. The studies prove that Verisol®’s peptides  result in:   

  • Reduced wrinkles and fine lines  
  • Increased elasticity and firmness   
  • Reduced cellulite  

At Oslo Skin Lab, we only work with products that have a proven, scientific effect, and we firmly believe in full-transparency for the things you chose to put into your bodies. All of these studies have been conducted in the same way and held to the same standards as medicinal studies. This means the studies were double-blind, randomized and placebo controlled, implying that the participants were randomly divided into two groups, where one group received the active ingredient (Verisol® collagen peptides), while the other group received a placebo (powder without active ingredient). Neither the participants in the studies nor the persons carrying out the measurements knew which group was which. In addition, the effect was measured using instruments that objectively report results. The studies were then peer-reviewed and published in medical databases.  

When reviewing these studies, keep in mind that “significant results” in scientific studies can only be achieved when there are enough participants and a large enough different between the placebo and tested group to prove more than just an “accident.” Thus, these studies all had a large enough participant pool and showed an overall significant difference in those who used The Solution’s collagen peptides vs. those who did not. 

WRINKLE DEPTH STUDY

WRINKLE DEPTH STUDY

20.1% AVERAGE REDUCTION IN WRINKLE DEPTH 

This study was conducted on 114 women aged 45-65 years. Participants received either 2.5 grams of Verisol® or a placebo once a day for eight weeks. Each participant had their skin objectively measured before starting treatment. After four weeks, the group that had received Verisol® showed a statistically significant reduction in wrinkle depth around the eyes of more than 7.2% on average. After eight weeks, the average reduction measured was a total 20.1%. (The maximum reduction in one of the participants was measured at 49.9%.)  

A sub-group was also organized and biopsies were taken of the skin both before and after treatment. The results of these biopsies showed excellent results in terms of the quality, elasticity and appearance of the skin.  

Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Skin Pharmacol Physiol. 2014;27(3):113-9.   

SKIN ELASTICITY STUDY 

SKIN ELASTICITY STUDY 

INCREASED SKIN ELASTICITY 

Sixty-nine healthy women aged 35-55 years participated in this study. Measurements of skin elasticity were taken for all participants after eight weeks of daily intake of either 2.5 grams of Verisol® collagen or a placebo. The skin's elasticity was measured using a vacuum instrument and the study showed a significant improvement for the group that had taken the Verisol® collagen compared to the placebo group.  

Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study.

Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S. Skin Pharmacol Physiol. 2014;27(1):47-55.